HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pablo Altman Selected Research

Salmeterol Xinafoate (Serevent)

12/2014INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pablo Altman Research Topics

Disease

11Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 04/2014
5Asthma (Bronchial Asthma)
01/2022 - 09/2018
2Dyspnea (Shortness of Breath)
01/2017 - 08/2015
1Nasal Polyps (Nasal Polyp)
01/2022
1Eosinophilia
01/2021
1Inflammation (Inflammations)
09/2018

Drug/Important Bio-Agent (IBA)

3prostaglandin D2 receptorIBA
01/2022 - 09/2018
3Prostaglandin D2IBA
01/2021 - 09/2018
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2020 - 12/2014
3Tiotropium Bromide (Spiriva)FDA Link
01/2018 - 01/2015
3Muscarinic AntagonistsIBA
01/2018 - 08/2015
3indacaterolIBA
01/2017 - 12/2014
3Bronchodilator Agents (Bronchodilators)IBA
01/2017 - 09/2014
2fevipiprantIBA
01/2022 - 01/2021
2Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2018 - 01/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022
1LipidsIBA
09/2018
1GoldIBA
08/2015
1Cholinergic Antagonists (Anticholinergics)IBA
01/2015
1Salmeterol Xinafoate (Serevent)FDA Link
12/2014
1Fluticasone (Cutivate)FDA LinkGeneric
12/2014

Therapy/Procedure

4Nebulizers and Vaporizers (Inhaler)
03/2020 - 01/2017
3Therapeutics
03/2020 - 04/2014
1Injections
03/2020
1Dry Powder Inhalers
06/2018
1Respiratory Therapy (Therapy, Respiratory)
06/2018
1Self Administration (Administration, Self)
06/2018